Research Paper Volume 15, Issue 13 pp 6135—6151
Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma
Figure 9. DRG.score in the role of anti-PD-1/L1 immunotherapy. (A) Differences in TIDE among high and low DRG.score groups. (B) Differences in DRG.score among non-response and response groups. (C) The proportion of non-response and response patients in low or high DRG.score groups. (D) Differences in DRG.score among TACE non-response and TACE response groups. (E) The proportion of TACE non-response and TACE response patients in low or high DRG.score groups.